Google
Trusted Resources: News & Events
Latest announcements and gatherings
Researchers Develop Test for SCA to be Used in Low-Resource Settings
Researchers have developed an accurate, low–cost potential test for diagnosing people with sickle cell anemia. The test, based on a lateral flow strip, is designed for use in areas where SCA treatment exists but testing methods are inaccessible, such as sub-Saharan Africa, where SCA is prominent.
While researchers were optimistic about the results, they recommended further testing to ensure the test’s reliability in warm climates and in the field.
The study, “Towards a point-of-care strip test to diagnose sickle cell anemia,” was published in PLOS One.
+myBinderRelated Content
-
Noninvasive Assessment of Liver Fibrosis in Patients with Sickle Cell DiseaseComplications affecting multiple organs,...
-
Discovery could help treatments for sickle cell diseaseResearch team establishes biomarkers for...
-
Prevention of Conversion to Abnormal Transcranial Doppler With Hydroxyurea in Sickle Cell Anemia: A Phase III Intern...Children with sickle cell anemia (SCA) a...
-
Ghana Launches Partnership With Novartis to Improve Diagnosis and Treatment of People With Sickle Cell DiseaseThe Government of Ghana announced a new ...
-
Small chips, big impact: MSU researcher studies cardiovascular, sickle cell diseaseA Mississippi State University researche...
-
Non-Invasive Prenatal Screening Test for Sickle Cell Appears Possible, Study ReportsA non-invasive prenatal test to diagnose...
-
Inexpensive sickle cell diagnostic tool shows perfect accuracy in UgandaAn inexpensive, easy-to-use diagnostic t...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.